Publication:
Hypertension in Women of Reproductive Age in the United States: NHANES 1999-2008

Thumbnail Image

Date

2012

Journal Title

Journal ISSN

Volume Title

Publisher

Public Library of Science
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Bateman, Brian T., Kate M. Shaw, Elena V. Kuklina, William M. Callaghan, Ellen W. Seely, and Sonia Hernández-Díaz. 2012. Hypertension in women of reproductive age in the United States: NHANES 1999-2008. PLoS ONE 7(4): e36171.

Research Data

Abstract

Objective: To examine the epidemiology of hypertension in women of reproductive age. Methods: Using NHANES from 1999–2008, we identified 5,521 women age 20–44 years old. Hypertension status was determined using blood pressure measurements and/or self-reported medication use. Results: The estimated prevalence of hypertension in women of reproductive age was 7.7% (95% confidence interval (CI): 6.9%–8.5%). The prevalence of anti-hypertensive pharmacologic therapy was 4.2% (95% CI 3.5%–4.9%). The prevalence of hypertension was relatively stable across the study period; the age and race adjusted odds of hypertension in 2007–2008 did not differ significantly from 1999–2000 (odds ratio 1.2, CI 0.8 to 1.7, p = 0.45). Significant independent risk factors associated with hypertension included older age, non-Hispanic black race (compared to non-Hispanic whites), diabetes mellitus, chronic kidney disease, and higher body mass index. The most commonly used antihypertensive medications included diuretics, angiotensin-converting enzyme inhibitors (ACE), and beta blockers. Conclusion: Hypertension occurs in about 8% of women of reproductive age. There are remarkable differences in the prevalence of hypertension between racial/ethnic groups. Obesity is a risk factor of particular importance in this population because it affects over 30% of young women in the U.S., is associated with more than 4 fold increased risk of hypertension, and is potentially modifiable.

Description

Keywords

Medicine, Cardiovascular, Cardiovascular Diseases in Women, Hypertension, Epidemiology, Cardiovascular Disease Epidemiology, Pharmacoepidemiology, Non-Clinical Medicine, Health Care Policy, Health Education and Awareness, Health Risk Analysis, Nutrition, Obesity, Obstetrics and Gynecology, Pregnancy, Hypertensive Disorders in Pregnancy, Pregnancy Complications, Public Health, Health Screening, Preventive Medicine, Women's Health

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories